Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Sarcoma Drugs Market

Sarcoma Drugs Market Share

Report ID: GMI9617
Published Date: May 2024
Report Format: PDF

Download Free Sample

Sarcoma Drugs Market Share

The sarcoma drugs industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive scanners with improved efficiency and affordability. This includes advancements in design, precision, automation, and customization. Competition is driven by factors such as the quality, reliability, and ease of usage along with integration capabilities with existing technologies, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.

Sarcoma Drugs Market Companies

Some of the eminent market participants operating in the sarcoma drugs industry include:

Abbott laboratories
AbbVie Inc.
Amneal Pharmaceuticals Inc.
Bausch Health Companies Inc.
Bayer AG
Baxter International Inc.
Bristol-Myers Squibb Company
GSK plc
Hikma Pharmaceuticals PLC
Johnson & Johnson
Lupin Limited
MERCK & CO., INC.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The sarcoma drugs market size was valued at USD 1.4 billion in 2023 and is estimated to grow at 8.5% CAGR from 2024 to 2032, driven by the increasing incidence of sarcomas, such as soft tissue sarcomas.

The chemotherapy treatment segment of the market recorded USD 602.1 million in 2023 and will expand rapidly through 2032, owing to its effectiveness in treating sarcomas that have spread to distant sites (metastatic disease).

U.S. sarcoma drugs market is anticipated to grow at 8.3% CAGR during 2024-2032, owing to an infrastructure that fosters collaboration, innovation, and the discovery of novel sarcoma drug candidates.

Abbott laboratories, AbbVie Inc, Amneal Pharmaceuticals Inc, Bausch Health Companies Inc, Bayer AG, Baxter International Inc, Bristol-Myers Squibb Company, and GSK plc among others.